Long-term Safety of TPN171H Tablet in Erectile Dysfunction.

PHASE3CompletedINTERVENTIONAL
Enrollment

472

Participants

Timeline

Start Date

April 12, 2024

Primary Completion Date

June 5, 2025

Study Completion Date

June 5, 2025

Conditions
Erectile Dysfunction
Interventions
DRUG

TPN171H

10 mg/ time, as needed, it is recommended to take warm water within 0.5 to 4 hours before sexual activity.

Trial Locations (34)

100032

Peking University First Hospital, Beijing

100191

Peking University Third Hospital, Beijing

116011

The Second Hospital of Dalian Medical University, Dalian

130021

The First Hospital of Jilin University, Changchun

215000

Second Affiliated Hospital of Suzhou University, Suzhou

230000

The First Affiliated Hospital of Anhui Medical University, Hefei

330001

Nanchang reproductive hospital, Nanchang

430014

The Central Hospital of Wuhan, Wuhan

430022

Wuhan Union Hospital, Wuhan

450100

Henan Provincial People's Hospital, Zhengzhou

510000

Guangzhou First People's Hospital, Guangzhou

510700

The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou

518105

Shenzhen Songgang People's Hospital, Shenzhen

Unknown

The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou

Shantou Central Hospital, Shantou

The Second Affiliated Hospital of Shantou University Medical College, Shantou

The 2nd Affiliated Hospital of Guilin Medical University, Guilin

The Affiliated Hospital of Guizhou Medical University, Guiyang

Qingyuan People's Hospital, Qingyuan

The Second Hospital of Hebei Medical Uniyersity, Shijiazhuang

Xingtai People's Hospital, Xingtai

The First Affiliated Hospital of Henan University, Zhengzhou

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha

Loudi Central Hospital, Loudi

Yueyang People's Hospital, Yueyang

Yichang Central People's Hospital (Xiling Campus), Yichang

Chifeng Municipal Hospital, Chifeng

The Affiliated Hospital of Qinghai University, Xining

Xianyang Central Hospital, Xianyang

The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xian

Nuclear Industry 416 Hospital, Chengdu

The Affiliated Hospital of Chengdu University, Chengdu

Suining Central Hospital, Suining

Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Ürümqi

All Listed Sponsors
lead

Vigonvita Life Sciences

INDUSTRY

NCT06301854 - Long-term Safety of TPN171H Tablet in Erectile Dysfunction. | Biotech Hunter | Biotech Hunter